1Montalescot G,Ankri A,Chadefanx VB,et al.Plasmahomocysteine and the extent of atherosclerosis in patients with coronarydisease[J].Int J Cardiol,1997,(60):295.
2Reece EA,Homke C,Wizntzer A.Metabolic changes in diabetic and mondiabetic subjects durny pregnancy[J].Obstet Gynecol Surv,1994,49(1):64-71.
3Simonsen O,Grubb A,Thysell H.The blood serum concentration ofcystatinC(gamma-trace)as a measure of the glomerular filtrationrate[J].Scand J Clin Lab Invest,1985,45(2):97-101.
4Rule AD,Berqstralh EJ,Slezak JM,et al.Glomerular filtration rateestimated by cystatin C among different clinical presentations[J].Kidney Int,2006,69(2):399-405.
6Koenig W,Twardella D,Brenner H,et al.Plasma concentrations ofcystatin C in patients with coronary heart disease and risk forsecondary cardiovascular events:more than simply a marker ofglomerular filtration rate[J].Clin Chem,2005,51(2):321-327.
7Clerico A,Fontana M,Zyw L,et al.Comparison of the diagnosticaccuracy of brain natriuretic peptide(BNP)and the N-terminal partof the propeptide of BNP immunoassays in chronic and acute heartfailure:a systematic review[J].Clin Chem,2007,53(5):813-822.
8Taglieri N,Koenig W,Kaski JC.Cystatin C and cardiovsacular risk[J].Clin Chem,2009,55(11):1932-1943.
9Matenzi G,Lauri G,Guazzi M,et al.Cardiac and renal dysfunctionin chronic heart failure:relation to neurohumoral activation andprognosis[J].Am J Med Sci,2001,321(6):359-366.
10Shlipak MG,Sarnak MJ,Katz R,et al.Cystatin C and the risk ofdeath and cardiovascular events among elderly persons[J].N EnglJ Med,2005,352(20):2049-2060.
